http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#head http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#assertion http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#assertion http://bio2rdf.org/drugbank:DB00872 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://bio2rdf.org/drugbank:DB00918 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://purl.org/dc/terms/identifier drugbank_resource:DB00872_DB00918 http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://purl.org/dc/terms/title DDI between Conivaptan and Almotriptan - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Almotriptan. Use an initial almotriptan dose of 6.25mg when using almotriptan with a strong CYP3A4 inhibitor, and do not exceed 12.5mg of almotriptan in any 24-hour period. Avoid concurrent use of almotriptan with a strong CYP3A4 inhibitor in patients with impaired hepatic or renal function. http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00872_DB00918 http://www.w3.org/2000/01/rdf-schema#label DDI between Conivaptan and Almotriptan - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Almotriptan. Use an initial almotriptan dose of 6.25mg when using almotriptan with a strong CYP3A4 inhibitor, and do not exceed 12.5mg of almotriptan in any 24-hour period. Avoid concurrent use of almotriptan with a strong CYP3A4 inhibitor in patients with impaired hepatic or renal function. [drugbank_resource:DB00872_DB00918] http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#provenance http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#publicationInfo http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#signature.MCwCFFV01Q7v10oJ http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#signature.MCwCFFV01Q7v10oJ http://purl.org/nanopub/x/hasSignature MCwCFFV01Q7v10oJtYIFULw6kjYH11k2AhQkoqzQ0PtICLNvEf5ciqgoPMlWMg== http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#signature.MCwCFFV01Q7v10oJ http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://purl.org/dc/terms/created 2018-03-30T11:12:27.825+02:00 http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80#signature.MCwCFFV01Q7v10oJ http://bio2rdf.org/drugbank_resource:DB00872_DB00918_nanopub.RAstVPi_OZ7MCH63TdOhyO5EZuy1L-L6MIUz3eugTKF80 http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234